Below are the top biotechnology stocks on the NASDAQ in terms of PEG ratio.
PDL BioPharma PDLI has a PEG ratio of 0.35. PDL BioPharma's trailing-twelve-month revenue is $442.90 million.
Enzymotec ENZY has a PEG ratio of 0.43. Enzymotec's trailing-twelve-month operating margin is 18.20%.
Questcor Pharmaceuticals QCOR has a PEG ratio of 0.50. Questcor Pharma's trailing-twelve-month EPS is $4.73.
INSYS Therapeutics INSY has a PEG ratio of 1.05. INSYS Therapeutics' trailing-twelve-month ROE is 165%.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in